Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.6800
-0.0300 (-4.23%)
Jul 8, 2025, 3:55 PM AEST

Argenica Therapeutics Revenue

Argenica Therapeutics had revenue of 2.83M AUD in the half year ending December 31, 2024, with 105.66% growth. This brings the company's revenue in the last twelve months to 3.08M, up 13.03% year-over-year. In the fiscal year ending June 30, 2024, Argenica Therapeutics had annual revenue of 2.60M with 48.46% growth.

Revenue (ttm)
3.08M
Revenue Growth
+13.03%
P/S Ratio
29.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
91.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20242.60M848.04K48.46%
Jun 30, 20231.75M1.49M575.38%
Jun 30, 2022259.10K-36.98K-12.49%
Jun 30, 2021296.08K--
Jun 30, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Ramsay Health Care 17.12B
Telix Pharmaceuticals 783.21M
Ansell 3.00B
Regis Healthcare 1.10B
Revenue Rankings